Testing effectiveness (Phase 2)Study completedNCT00386685What this trial is testingXRP9881 in Combination With Trastuzumab in Metastatic Breast CancerWho this might be right forBreast Neoplasms Sanofi 51
Large-scale testing (Phase 3)UnknownNCT01126138What this trial is testingCapecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)Who this might be right forCarcinoma, Invasive Ductal, Breast Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Study completedNCT00629148What this trial is testingSequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)Who this might be right forBreast CancerMetastasis, Neoplasm Fudan University 60
Not applicableLooking for participantsNCT06830382What this trial is testingHER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBCWho this might be right forBreast Cancer Stage IVHER2-low Breast CancerMolecular Imaging Renske Altena 70
Testing effectiveness (Phase 2)Study completedNCT01306942What this trial is testingDasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC PatientsWho this might be right forMetastatic Breast Cancer Spanish Breast Cancer Research Group 37
Large-scale testing (Phase 3)UnknownNCT04385563What this trial is testingEvaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.Who this might be right forHER2-positive Metastatic Breast Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 338
Testing effectiveness (Phase 2)Ended earlyNCT02202746What this trial is testingAssess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast CancerWho this might be right forBreast CancerMetastatic Breast CancerMBC+5 more Clovis Oncology, Inc. 178
Not applicableStudy completedNCT02436772What this trial is testingUtilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBCWho this might be right forMetastatic Breast Cancer SCRI Development Innovations, LLC 74
Testing effectiveness (Phase 2)Looking for participantsNCT06369831What this trial is testingHER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011Who this might be right forMetastatic Breast Cancer Abscint NV/SA 60
Testing effectiveness (Phase 2)Ended earlyNCT03070002What this trial is testingDenosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor CellsWho this might be right forBreast Carcinoma Metastatic in the BoneCirculating Tumor Cell CountEstrogen Receptor Positive+3 more Northwestern University 1
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Large-scale testing (Phase 3)Active Not RecruitingNCT03315364What this trial is testingOral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line TherapyWho this might be right forRecurrent or Metastatic Breast Cancer Daehwa Pharmaceutical Co., Ltd. 549
Not applicableUnknownNCT03245112What this trial is testingHalaven Patient Registry (Metastatic Breast Cancer, MBC)Who this might be right forMetastatic Breast CancerAdvanced Breast Cancer Chang Gung Memorial Hospital 500
Early research (Phase 1)Study completedNCT00788931What this trial is testingA Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast CancerWho this might be right forHER-2 Positive Breast CancerMetastatic Breast Cancer Novartis Pharmaceuticals 15
Testing effectiveness (Phase 2)UnknownNCT05833919What this trial is testingSecond Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer PatientsWho this might be right forMetastatic Breast Cancer Consorzio Oncotech 122
Testing effectiveness (Phase 2)Study completedNCT00532714What this trial is testingPhase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBCWho this might be right forBreast Cancer Metastatic National Cancer Center, Korea 36
Early research (Phase 1)Study completedNCT05501769What this trial is testingARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast CancerWho this might be right forBreast Cancer Arvinas Estrogen Receptor, Inc. 32
Not applicableLooking for participantsNCT07066917What this trial is testingMechanisms of Response and Resistance to Innovative Treatments in Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Hellenic Cooperative Oncology Group 150
Testing effectiveness (Phase 2)Study completedNCT00509769What this trial is testingTrastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Genentech, Inc. 112
Not applicableUnknownNCT04852081What this trial is testingAnalysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.Who this might be right forBreast Cancer Stage IV Blokhin's Russian Cancer Research Center 1,000